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Background
There are indications, according to WHO, that diabetes
will reach 333 million people in 2025, and already is
among one of the main death causes in the world. In 2030
in Latin America, diabetes mellitus will be the second
cause of deaths [1]. The actions to increase the production
of insulin are strategic to respond the high demands for
what we have to face in the near future [2]. P. pastoris
methylotrophic yeast is being very used in the last decades
to express heterologous genes to biotech uses [3]. The
main expression vectors to Pichia pastoris are based in the
strong promoter from AOX1 gene which codifies alcohol
oxidize enzyme. However there is a search for new promo-
ters than AOX1 due to certain disadvantages as the use of
methanol as inducer that is toxic and originates undesir-
able subproducts during its metabolism [4]. This work has
the main objective in to express in high levels the human
proinsulin in Pichia pastoris using PGK promoter.
Methods
The human proinsulin codifing sequence was chemically
synthesized (Genone inc.) with P. pastoris optimized
codons. The synthesized sequence was subcloned under
PGK promoter control in expression vector together with
the codifying region from Saccaromyces cerevisiae factor-
a signal peptide in order to have proinsulin expression/
secretion. After linearization the vector containing the
expression cassete was introduced in P. pastoris GS115
by electroporation. To select clones, with multicopies of
expression cassette, was realized a zeocin resistance test
in plate [5]. Resistant clones to 100 μg/mL of zeocin were
selected and submitted to crescent concentrations of the
antibiotic: 500, 1000 and 2000 μg/mL. The recombinant
clones that produced/secreted more proinsulin was
detected by imunodot procedure using antibody anti-
insulin/proinsulin (Pierce-D3E7/5B6/6). Selected recom-
binant clones were cultivated in YPD medium for 24
hours in 30°C at 200rpm and the supernatants were clari-
fied by centrifugation and analyzed by ELISA and Wes-
tern-blotting.
Results and conclusion
From 200 zeocin (100 µg/mL) resistant P. pastoris clones
25 were able to grow in 2000 µg/mL which indicates that
they have integrated several expression/ secretion cas-
setes in their genomes. From those one was notable for
its higher human proinsulin expression/secretion in both
experiments (imunodot and ELISA). The proinsulin over-
expression of this selected clone was confirmed by PAGE
and Western-blotting with anti-insulin/anti-proinsulin
antibody. Additional experiments are in process in order
to standardize the fermentative process for expression
and secretion of human proinsulin as well as confirm
recombinant protein amino acid sequence.
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